Nasdaq Biotechnology Ishares (IBB) 325.46 $IBB
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - 38 mins ago
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 104.32 (-1.22), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
3 Biotech Stocks to Buy in November
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sun Nov 01, 12:20PM CST
Image Source TBIT via pixabay Well, that was fast. A month ago it seemed like biotech stocks couldn't do anything right. Shares of the iShares Nasdaq Biotechnology ETF , which holds a huge collection of biotech stocks, were pummeled over fears...
SGYP: 6.41 (-0.22), IRWD: 11.36 (+0.16), ALXN: 176.00 (+0.05), IBB: 325.46 (-3.09), EXEL: 6.02 (+0.14)
Betting Big on Beleaguered Biotechs
at The Street - Thu Oct 29, 3:00PM CDT
Investor's holdings have fallen along with the sector, but he's raising the stakes.
OREX: 3.04 (+0.05), BITI: 13.11 (-0.19), IBB: 325.46 (-3.09), ATRA: 25.77 (+0.14), KERX: 4.48 (-0.03)
After Yesterday's Rally of 3.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 27, 3:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $317.74 to a high of $327.65. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $322.21 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 3.21% Yesterday
Comtex SmarTrend(R) - Tue Oct 27, 3:56PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $317.74 to a high of $327.65. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $322.21 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
BUYINS.NET: IGV, IYH, VGT, IBB, VHT, IYW Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Oct 27, 7:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares S&P North Amer Technology-Software Idx Fd (NYSE:IGV), iShares Dow Jones US Healthcare Sector Index Fund (NYSE:IYH), Vanguard Information Technology Etf (NYSE:VGT), Ishares Nasdaq Biotechnology (NASDAQ:IBB), Vanguard Health Care Etf (NYSE:VHT), iShares Dow Jones US Technology Sector Index Fund (NYSE:IYW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
IGV: 103.37 (-0.24), IYH: 150.03 (-0.74), IBB: 325.46 (-3.09), VGT: 110.46 (-0.56), VHT: 130.93 (-0.73), IYW: 109.24 (-0.72)
Why Keryx Biopharmaceuticals Was Obliterated in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 5:01PM CDT
Shares of Keryx Biopharmaceuticals , a drug developer with a focus on renal disease, had an awful month: Shares were down nearly 40% in September. What caused the huge downward move? See the presentation below for details. The next...
IBB: 325.46 (-3.09), KERX: 4.48 (-0.03)
Why Shares of Aratana Therapeutics Fell Off a Cliff in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 3:16PM CDT
Shares of Aratana Therapeutics , a small-cap company focused on animal health, dropped more than 50% in September after the company released disappointing clinical trial results. Is this drop a buying opportunity? See the presentation below for...
IBB: 325.46 (-3.09), PETX: 6.99 (+0.01)
Why Shares of Theravance Inc Dropped 49% in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 2:03PM CDT
Shares of Theravance , a healthcare royalty management company for a focus on respiratory products, were down big during September after the company and its partner GlaxoSmithKline PLC released disappointing clinical news. Are the shares a buy...
IBB: 325.46 (-3.09), THRX: 8.78 (-0.03), GSK: 43.06 (+0.27)
Why Shares of Zogenix Inc Fell 26% in September
Brian Feroldi, The Motley Fool - Motley Fool - Sat Oct 24, 5:08PM CDT
Shares of Zogenix , a small-cap pharmaceutical company with a focus on disorders of the central never system, fell hard during the month of September. Was the sell-off justified? Read the short presentation below to get all of the details. ...
ZGNX: 11.79 (-0.07), IBB: 325.46 (-3.09)
iShares Nasdaq Biotechnology Index Rises 3.32% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 23, 4:29PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $308.67 to a high of $316.31. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $316.26 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 3.32% Gain
Comtex SmarTrend(R) - Fri Oct 23, 4:28PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $308.67 to a high of $316.31. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $316.26 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
RBC Capital Markets Says Buy These 5 Pharmaceutical Stocks, Despite 'Irrational' Sell Off
at The Street - Thu Oct 22, 9:46AM CDT
The selloff in specialty pharmaceutical stocks has found a new "irrational low," following Wednesday's attack on Valeant Pharmaceuticals, according to RBC Capital Markets.
AGN: 308.47 (+4.09), ENDP: 59.99 (-0.39), INSY: 25.76 (-0.27), VRX: 93.77 (-17.73), SGNT: 16.81 (-0.10), IBB: 325.46 (-3.09), TEVA: 59.19 (-1.05)
Biotech Stocks Slump Again on Valeant's 'Smoking Gun'
at The Street - Wed Oct 21, 3:02PM CDT
Biotech stocks were in the crossfire again on Wednesday as investors fled. But this time Hillary Clinton wasn't to blame.
KO: 42.35 (-0.44), VRX: 93.77 (-17.73), F: 14.81 (+0.08), KMB: 119.71 (-2.06), PFE: 33.82 (-0.95), IBB: 325.46 (-3.09), FCAU: 14.64 (+0.08), LLY: 81.57 (-0.43), TM: 122.62 (-0.62), BMY: 65.95 (-1.36), BA: 148.07 (+0.89), GM: 34.91 (+0.16), ABBV: 59.55 (+5.45), HMC: 33.13 (+0.15), RACE: 50.43 (-0.59)
Stocks Fall; Valeant Defends Accounting Practices
at The Street - Wed Oct 21, 2:02PM CDT
Stocks relinquish gains made earlier Wednesday as a selloff in Valeant Pharmaceuticals pressures the rest of the biotech sector.
TSLA: 206.93 (-4.70), BIIB: 290.51 (-3.21), F: 14.81 (+0.08), VRX: 93.77 (-17.73), KMB: 119.71 (-2.06), IBB: 325.46 (-3.09), TM: 122.62 (-0.62), SBUX: 62.57 (+0.07), YHOO: 35.62 (+0.57), CMG: 640.23 (-7.97), ABBV: 59.55 (+5.45), GOOGL: 737.39 (-7.46), HMC: 33.13 (+0.15), AAPL: 119.50 (-1.03), KO: 42.35 (-0.44), AMZN: 625.90 (-0.65), MU: 16.56 (+0.35), PFE: 33.82 (-0.95), LLY: 81.57 (-0.43), FCAU: 14.64 (+0.08), BMY: 65.95 (-1.36), BA: 148.07 (+0.89), WDC: 66.82 (-1.00), LRCX: 76.59 (+0.75), MCD: 112.25 (-0.37), GM: 34.91 (+0.16), KLAC: 67.12 (+0.80), RACE: 50.43 (-0.59), SNDK: 77.00 (-0.22)
Carl Icahn Forming Super PAC to Push Corporate Tax Reform
at The Street - Wed Oct 21, 1:26PM CDT
The CNBC 'Fast Money' traders get the latest on the Valeant Pharma stock plunge, then hear from Carl Icahn on why he's forming a super PAC focused on corporate taxes.
VRX: 93.77 (-17.73), SPY: 207.93 (-0.90), GM: 34.91 (+0.16), IBB: 325.46 (-3.09), BA: 148.07 (+0.89), AAPL: 119.50 (-1.03)
Stocks Turn Lower as Valeant Dents Biotech Sector
at The Street - Wed Oct 21, 9:41AM CDT
Stocks turn lower by mid-morning Wednesday as plummeting Valeant Pharmaceuticals shares pull the biotech sector to the downside.
BIIB: 290.51 (-3.21), TSLA: 206.93 (-4.70), VRX: 93.77 (-17.73), KMB: 119.71 (-2.06), IBB: 325.46 (-3.09), SBUX: 62.57 (+0.07), YHOO: 35.62 (+0.57), CMG: 640.23 (-7.97), ABBV: 59.55 (+5.45), GOOGL: 737.39 (-7.46), AAPL: 119.50 (-1.03), KO: 42.35 (-0.44), AMZN: 625.90 (-0.65), MU: 16.56 (+0.35), PFE: 33.82 (-0.95), FCAU: 14.64 (+0.08), BA: 148.07 (+0.89), WDC: 66.82 (-1.00), CELG: 122.71 (-2.22), GILD: 108.13 (-1.08), LRCX: 76.59 (+0.75), GM: 34.91 (+0.16), MCD: 112.25 (-0.37), KLAC: 67.12 (+0.80), RACE: 50.43 (-0.59), SNDK: 77.00 (-0.22)
Stocks Slide as Health Care Selloff Dings Nasdaq
at The Street - Tue Oct 20, 1:37PM CDT
Stocks are lower by mid-afternoon Tuesday, pulled down by weakness in the tech and health care sectors.
BIIB: 290.51 (-3.21), TSLA: 206.93 (-4.70), GE: 28.92 (-0.42), VRX: 93.77 (-17.73), HOG: 49.45 (-0.51), UTX: 98.41 (-0.64), TFM: 24.92 (-0.16), IBB: 325.46 (-3.09), T: 33.51 (-0.04), SONC: 28.54 (-0.59), IBM: 140.08 (-0.47), S: 4.73 (-0.07), XLK: 43.65 (-0.29), SYF: 30.76 (-0.16), GOOGL: 737.39 (-7.46), TMUS: 37.89 (+0.41), YUM: 70.91 (-1.60), TRV: 112.89 (-1.40), AMSG: 70.09 (-1.42), AMZN: 625.90 (-0.65), PFE: 33.82 (-0.95), WDC: 66.82 (-1.00), VOD: 32.97 (-0.03), UAL: 60.31 (+0.06), NFLX: 108.38 (+3.26), LVLT: 50.95 (+0.02), GILD: 108.13 (-1.08), WTW: 15.38 (-0.37), TMH: 59.67 (+0.38), VZ: 46.88 (+0.48), SNDK: 77.00 (-0.22), BABA: 83.83 (+1.61)
Breakthrough Biotech ETF on Cancer Treatment
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 12:54PM CDT
Want exposure to an innovative biotech field? The first cancer immunotherapy ETF (CNCR) is now within your reach.
BBP: 30.67 (+0.19), BBC: 27.39 (-0.31), SBIO: 29.73 (-0.19), CNCR: 27.65 (-0.24), IBB: 325.46 (-3.09), XLV: 71.34 (-0.45)
Bull of the Day: Repligen (RGEN)
Kevin Cook - ZACKS - Mon Oct 19, 9:01AM CDT
Bull of the Day: Repligen (RGEN)
RGEN: 33.24 (+0.32), GE: 28.92 (-0.42), TMO: 130.78 (-0.60), IBB: 325.46 (-3.09)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - 38 mins ago
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 104.32 (-1.22), XBI: 66.63 (-0.68), IBB: 325.46 (-3.09)
3 Biotech Stocks to Buy in November
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sun Nov 01, 12:20PM CST
Image Source TBIT via pixabay Well, that was fast. A month ago it seemed like biotech stocks couldn't do anything right. Shares of the iShares Nasdaq Biotechnology ETF , which holds a huge collection of biotech stocks, were pummeled over fears...
SGYP: 6.41 (-0.22), IRWD: 11.36 (+0.16), ALXN: 176.00 (+0.05), IBB: 325.46 (-3.09), EXEL: 6.02 (+0.14)
Betting Big on Beleaguered Biotechs
at The Street - Thu Oct 29, 3:00PM CDT
Investor's holdings have fallen along with the sector, but he's raising the stakes.
OREX: 3.04 (+0.05), BITI: 13.11 (-0.19), IBB: 325.46 (-3.09), ATRA: 25.77 (+0.14), KERX: 4.48 (-0.03)
After Yesterday's Rally of 3.21% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Oct 27, 3:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $317.74 to a high of $327.65. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $322.21 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 3.21% Yesterday
Comtex SmarTrend(R) - Tue Oct 27, 3:56PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $317.74 to a high of $327.65. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high of $322.21 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
BUYINS.NET: IGV, IYH, VGT, IBB, VHT, IYW Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Oct 27, 7:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares S&P North Amer Technology-Software Idx Fd (NYSE:IGV), iShares Dow Jones US Healthcare Sector Index Fund (NYSE:IYH), Vanguard Information Technology Etf (NYSE:VGT), Ishares Nasdaq Biotechnology (NASDAQ:IBB), Vanguard Health Care Etf (NYSE:VHT), iShares Dow Jones US Technology Sector Index Fund (NYSE:IYW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
IGV: 103.37 (-0.24), IYH: 150.03 (-0.74), IBB: 325.46 (-3.09), VGT: 110.46 (-0.56), VHT: 130.93 (-0.73), IYW: 109.24 (-0.72)
Why Keryx Biopharmaceuticals Was Obliterated in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 5:01PM CDT
Shares of Keryx Biopharmaceuticals , a drug developer with a focus on renal disease, had an awful month: Shares were down nearly 40% in September. What caused the huge downward move? See the presentation below for details. The next...
IBB: 325.46 (-3.09), KERX: 4.48 (-0.03)
Why Shares of Aratana Therapeutics Fell Off a Cliff in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 3:16PM CDT
Shares of Aratana Therapeutics , a small-cap company focused on animal health, dropped more than 50% in September after the company released disappointing clinical trial results. Is this drop a buying opportunity? See the presentation below for...
IBB: 325.46 (-3.09), PETX: 6.99 (+0.01)
Why Shares of Theravance Inc Dropped 49% in September
Brian Feroldi, The Motley Fool - Motley Fool - Sun Oct 25, 2:03PM CDT
Shares of Theravance , a healthcare royalty management company for a focus on respiratory products, were down big during September after the company and its partner GlaxoSmithKline PLC released disappointing clinical news. Are the shares a buy...
IBB: 325.46 (-3.09), THRX: 8.78 (-0.03), GSK: 43.06 (+0.27)
Why Shares of Zogenix Inc Fell 26% in September
Brian Feroldi, The Motley Fool - Motley Fool - Sat Oct 24, 5:08PM CDT
Shares of Zogenix , a small-cap pharmaceutical company with a focus on disorders of the central never system, fell hard during the month of September. Was the sell-off justified? Read the short presentation below to get all of the details. ...
ZGNX: 11.79 (-0.07), IBB: 325.46 (-3.09)
iShares Nasdaq Biotechnology Index Rises 3.32% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 23, 4:29PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $308.67 to a high of $316.31. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $316.26 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 3.32% Gain
Comtex SmarTrend(R) - Fri Oct 23, 4:28PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $308.67 to a high of $316.31. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $316.26 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 325.46 (-3.09)
RBC Capital Markets Says Buy These 5 Pharmaceutical Stocks, Despite 'Irrational' Sell Off
at The Street - Thu Oct 22, 9:46AM CDT
The selloff in specialty pharmaceutical stocks has found a new "irrational low," following Wednesday's attack on Valeant Pharmaceuticals, according to RBC Capital Markets.
AGN: 308.47 (+4.09), ENDP: 59.99 (-0.39), INSY: 25.76 (-0.27), VRX: 93.77 (-17.73), SGNT: 16.81 (-0.10), IBB: 325.46 (-3.09), TEVA: 59.19 (-1.05)
Biotech Stocks Slump Again on Valeant's 'Smoking Gun'
at The Street - Wed Oct 21, 3:02PM CDT
Biotech stocks were in the crossfire again on Wednesday as investors fled. But this time Hillary Clinton wasn't to blame.
KO: 42.35 (-0.44), VRX: 93.77 (-17.73), F: 14.81 (+0.08), KMB: 119.71 (-2.06), PFE: 33.82 (-0.95), IBB: 325.46 (-3.09), FCAU: 14.64 (+0.08), LLY: 81.57 (-0.43), TM: 122.62 (-0.62), BMY: 65.95 (-1.36), BA: 148.07 (+0.89), GM: 34.91 (+0.16), ABBV: 59.55 (+5.45), HMC: 33.13 (+0.15), RACE: 50.43 (-0.59)
Stocks Fall; Valeant Defends Accounting Practices
at The Street - Wed Oct 21, 2:02PM CDT
Stocks relinquish gains made earlier Wednesday as a selloff in Valeant Pharmaceuticals pressures the rest of the biotech sector.
TSLA: 206.93 (-4.70), BIIB: 290.51 (-3.21), F: 14.81 (+0.08), VRX: 93.77 (-17.73), KMB: 119.71 (-2.06), IBB: 325.46 (-3.09), TM: 122.62 (-0.62), SBUX: 62.57 (+0.07), YHOO: 35.62 (+0.57), CMG: 640.23 (-7.97), ABBV: 59.55 (+5.45), GOOGL: 737.39 (-7.46), HMC: 33.13 (+0.15), AAPL: 119.50 (-1.03), KO: 42.35 (-0.44), AMZN: 625.90 (-0.65), MU: 16.56 (+0.35), PFE: 33.82 (-0.95), LLY: 81.57 (-0.43), FCAU: 14.64 (+0.08), BMY: 65.95 (-1.36), BA: 148.07 (+0.89), WDC: 66.82 (-1.00), LRCX: 76.59 (+0.75), MCD: 112.25 (-0.37), GM: 34.91 (+0.16), KLAC: 67.12 (+0.80), RACE: 50.43 (-0.59), SNDK: 77.00 (-0.22)
Carl Icahn Forming Super PAC to Push Corporate Tax Reform
at The Street - Wed Oct 21, 1:26PM CDT
The CNBC 'Fast Money' traders get the latest on the Valeant Pharma stock plunge, then hear from Carl Icahn on why he's forming a super PAC focused on corporate taxes.
VRX: 93.77 (-17.73), SPY: 207.93 (-0.90), GM: 34.91 (+0.16), IBB: 325.46 (-3.09), BA: 148.07 (+0.89), AAPL: 119.50 (-1.03)
Stocks Turn Lower as Valeant Dents Biotech Sector
at The Street - Wed Oct 21, 9:41AM CDT
Stocks turn lower by mid-morning Wednesday as plummeting Valeant Pharmaceuticals shares pull the biotech sector to the downside.
BIIB: 290.51 (-3.21), TSLA: 206.93 (-4.70), VRX: 93.77 (-17.73), KMB: 119.71 (-2.06), IBB: 325.46 (-3.09), SBUX: 62.57 (+0.07), YHOO: 35.62 (+0.57), CMG: 640.23 (-7.97), ABBV: 59.55 (+5.45), GOOGL: 737.39 (-7.46), AAPL: 119.50 (-1.03), KO: 42.35 (-0.44), AMZN: 625.90 (-0.65), MU: 16.56 (+0.35), PFE: 33.82 (-0.95), FCAU: 14.64 (+0.08), BA: 148.07 (+0.89), WDC: 66.82 (-1.00), CELG: 122.71 (-2.22), GILD: 108.13 (-1.08), LRCX: 76.59 (+0.75), GM: 34.91 (+0.16), MCD: 112.25 (-0.37), KLAC: 67.12 (+0.80), RACE: 50.43 (-0.59), SNDK: 77.00 (-0.22)
Stocks Slide as Health Care Selloff Dings Nasdaq
at The Street - Tue Oct 20, 1:37PM CDT
Stocks are lower by mid-afternoon Tuesday, pulled down by weakness in the tech and health care sectors.
BIIB: 290.51 (-3.21), TSLA: 206.93 (-4.70), GE: 28.92 (-0.42), VRX: 93.77 (-17.73), HOG: 49.45 (-0.51), UTX: 98.41 (-0.64), TFM: 24.92 (-0.16), IBB: 325.46 (-3.09), T: 33.51 (-0.04), SONC: 28.54 (-0.59), IBM: 140.08 (-0.47), S: 4.73 (-0.07), XLK: 43.65 (-0.29), SYF: 30.76 (-0.16), GOOGL: 737.39 (-7.46), TMUS: 37.89 (+0.41), YUM: 70.91 (-1.60), TRV: 112.89 (-1.40), AMSG: 70.09 (-1.42), AMZN: 625.90 (-0.65), PFE: 33.82 (-0.95), WDC: 66.82 (-1.00), VOD: 32.97 (-0.03), UAL: 60.31 (+0.06), NFLX: 108.38 (+3.26), LVLT: 50.95 (+0.02), GILD: 108.13 (-1.08), WTW: 15.38 (-0.37), TMH: 59.67 (+0.38), VZ: 46.88 (+0.48), SNDK: 77.00 (-0.22), BABA: 83.83 (+1.61)
Breakthrough Biotech ETF on Cancer Treatment
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 12:54PM CDT
Want exposure to an innovative biotech field? The first cancer immunotherapy ETF (CNCR) is now within your reach.
BBP: 30.67 (+0.19), BBC: 27.39 (-0.31), SBIO: 29.73 (-0.19), CNCR: 27.65 (-0.24), IBB: 325.46 (-3.09), XLV: 71.34 (-0.45)
Bull of the Day: Repligen (RGEN)
Kevin Cook - ZACKS - Mon Oct 19, 9:01AM CDT
Bull of the Day: Repligen (RGEN)
RGEN: 33.24 (+0.32), GE: 28.92 (-0.42), TMO: 130.78 (-0.60), IBB: 325.46 (-3.09)
